Rating History for Emergent BioSolutions (EBS) by Chardan Capital Markets
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
11/10/2021 | Keay Nakae | Maintain | Buy (N/A) |
75.00 (92.00) |
|
Details | |
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
11/10/2021 | Keay Nakae | Maintain | Buy (N/A) |
75.00 (92.00) |
|
Details | |